Doctoral dissertations supervised/co-supervised by/carried out in collaboration with the researchers at the Department of Clinical Pharmacology, University of Helsinki.
2018
2017
2016
2015
2014
2012
- Tuija Tapaninen
- Tiina Karonen
- Erik Litonius
2011
- Johanna Honkalammi
- Xiaoqiang Xiang
2009
- Marjo Volotinen
- Samuel Fanta
- Mika Isohanni
2008
- Annikka Kalliokoski
- Marjo Karjalainen
- Henna Rautiainen
- Kati Ahonen
- Kim Lemberg
- Marja Pasanen
- Aleksi Tornio
2007
2006
- Lauri Kajosaari
- Mia Koskinen
- Pentti Pöder
2005
- Marika Granfors
- Heli Malm
- Heikki Valleala
2004
2003
- Hanna Kotikoski
- Kristiina Perttunen
- Mika Jokinen
- Matti Kivikko
- Kari Raaska
2002
2001
- Outi Lapatto-Reiniluoto
- Elina Saarenmaa
- Jun-Sheng Wang
- Jari Lilja
- Mikko Niemi
2000
1999
- Teemu Kantola, Effects of itraconazole and some other CYP3A4 inhibitors on the pharmacokinetics of HMG-CoA reductase inhibitors.
- Vilja Palkama, Studies on drug interactions between CYP3A4 inhibitors and anaesthetic drugs.
- Kirsti Villikka, Studies on drug interactions caused by rifampicin and dexamethasone in humans.
1998
- Tommi Lamberg, Effects of inhibition and induction of CYP3A4 on the pharmacokinetics and pharmacodynamics of buspirone.
1997
- Mirja Hämäläinen, L: Optimal drug treatment of recurrent headaches and migraine in children – a clinical and pharmacological study.
- Kirsi-Maija Kaukonen, Studies on the effects of a CYP3A4-inhibitor, itraconazole, on the pharmacokinetics and pharmacodynamcis of cardiovascular drugs.
- Seppo Kähkönen, Pharmacodynamic and pharmacokinetic aspects of propranolol, verapamil and isosorbide dinitrate during alcohol withdrawal.
- Eeva Lukkari, Clinical pharmacology of oxybutynin, with special reference to pharmacokinetics and interaction.
1996
- Reijo Laaksonen, The effect of HMG-CoA reductase inhibitor treatment on serum and skeletal muscle ubiquinone.
- Jouni Ahonen, Studies on CYP3A mediated drug interactions in anaesthesiology.
- Ari Illi, Inhibition of catechol-O-methyltransferase by entacapone: Effects on haemodynamics and catecholamine metabolism and interactions with drugs interfering with catecholamine disposition.
- Harri Luurila, Effect of erythromycin on the pharmacokinetics and pharmacodynamics of hypnotics.
- Anu Varhe, Interactions of triazolam with inhibitors of CYP3A enzymes.
1995
- Janne Backman, Effects of drugs inhabiting and inducing CYP3A enzymes on the pharmacokinetics and pharmacodynamics of oral midazolam.
1994
1993
1990
- Riitta Tokola, Studies on drug absorption and efficacy in migraine attacks.
1989
1987
- Kalle Hoppu, Paediatric clinical pharmacology of trimethoprim.
1987
- Eero Tiula, Effect of renal diseases on serum protein binding of drugs.
1985
- Klaus Olkkola, Factors affecting the antidotal efficacy of oral activated charcoal.
1982
- Jaakko-Juhani Himberg, Optimization and validation of gas-chromatographic drug assays for pharmacokinetic studies.
1981
1980
- Sirkka Elfving, Studies on the naturally occurring goitrogen 5-vinyl-2-thiooxazolidone – metabolism and antithyroid effect in the rat.